The United States and United Kingdom are leading a rush to strike deals with drugmakers to reserve supplies of experimental coronavirus vaccines, as the race to develop a safe and effective vaccine reaches the final stages of testing. There are currently no approved vaccines for COVID-19, with over 25 candidates being studied in humans. The following is a list of supply deals for potential vaccines th
The European Union has agreed to buy at least 300 million doses of AstraZeneca's potential COVID-19 vaccine, with an option to buy another 100 million. Drugmakers are racing to combat the pandemic that has killed about 760,000 people and infected nearly 21 million. There are no approved vaccines for COVID-19, but AstraZeneca's shot is widel
U.S. House of Representatives Republican leader Kevin McCarthy said on Friday that Democratic legislation on coronavirus relief would undermine the stock market, if enacted into law.
* Over 300 million doses secured to up chances of one that works
U.S. government scientists have begun efforts to manufacture a strain of the novel coronavirus that could be used in human challenge trials of vaccines, a controversial type of study in which healthy volunteers would be vaccinated and then intentionally infected with the virus, Reuters has learned.
New Zealand extended a lockdown in the country's biggest city in response to the first national coronavirus outbreak in months, while Britons were rushing back from summer holidays in France ahead of the planned 14-day quarantine for all travellers from across the Channel.
U.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373.
CureVac BV said on Friday it raised $213.3 million in its initial public offering in New York, setting the stage for the first stock market debut of a company developing a potential vaccine to combat the coronavirus.
1/WALL STREET WATCHES WASHINGTON U.S. lawmakers negotiating a fresh dose of stimulus have reached an impasse.
1/WALL STREET WATCHES WASHINGTON U.S. lawmakers negotiating a fresh dose of stimulus have reached an impasse.
U.S President Donald Trump is powering ahead with his anti-immigration agenda, even as voters say they are more concerned with the coronavirus pandemic and the economic destruction it has wrought.